Efficacy of the sentinox spray in reducing viral load in mild COVID-19 and its virucidal activity against other respiratory viruses: results of a randomized controlled trial …

D Panatto, A Orsi, B Bruzzone, V Ricucci, G Fedele… - Viruses, 2022 - mdpi.com
Sentinox (STX) is an acid-oxidizing solution containing hypochlorous acid in spray whose
virucidal activity against SARS-CoV-2 has been demonstrated. In this paper, results of a …

A Prospective Study of AFree Oral Spray as an Adjuvant Therapy for Mild and Moderate COVID-19 in Community Health Stations: Clinical Progression and Viral …

DT Tran, TN Pham, NHT Nguyen, HD Tran, HQ Hoang… - in vivo, 2023 - iv.iiarjournals.org
Background/Aim: The aim of this study was to evaluate the safety and efficacy of AFree oral
spray, in combination with Standard of Care, in treating mild to moderate COVID-19 patients …

[HTML][HTML] Astodrimer Sodium Nasal Spray versus Placebo in Non-Hospitalised Patients with COVID-19: A Randomised, Double-Blinded, Placebo-Controlled Trial

S Winchester, A Castellarnau, K Jabbar, M Nadir… - Pharmaceutics, 2024 - mdpi.com
Background/Objectives: Dendrimer-based astodrimer sodium nasal spray was assessed for
its ability to reduce SARS-CoV-2 load in outpatients with COVID-19, which remains a severe …

Efficacy of “essential iodine drops” against severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2)

Z Köntös - Plos one, 2021 - journals.plos.org
Background Aerosolization of respiratory droplets is considered the main route of
coronavirus disease 2019 (COVID-19). Therefore, reducing the viral load of Severe Acute …

Inactivation of SARS‐CoV‐2 and HCoV‐229E in vitro by ColdZyme® a medical device mouth spray against the common cold

Á Gudmundsdottir, R Scheving… - Journal of Medical …, 2021 - Wiley Online Library
Background The coronavirus disease 2019 (COVID‐19) pandemic calls for effective and
safe treatments. Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) causing …

Hypochlorous acid solution is a potent antiviral agent against SARS‐CoV‐2

N Hatanaka, M Yasugi, T Sato… - Journal of Applied …, 2022 - academic.oup.com
Aim A novel coronavirus, termed severe acute respiratory syndrome coronavirus 2 (SARS‐
CoV‐2) suddenly appeared in Wuhan, China, and has caused pandemic. In this study, we …

Evaluation the efficacy and safety of N‐acetylcysteine inhalation spray in controlling the symptoms of patients with COVID‐19: An open‐label randomized controlled …

Y Panahi, M Ghanei, M Rahimi, A Samim… - Journal of Medical …, 2023 - Wiley Online Library
The aim of this study was to evaluate the effect and safety of N‐acetylcysteine (NAC)
inhalation spray in the treatment of patients with coronavirus disease 2019 (COVID‐19). This …

[HTML][HTML] In-vitro for Q-RT-PCR clinical evaluation of oscardia ledovir spray effectiveness on SARS-CoV-2 and its effective variants

Y Artik, MS Kurtulmuş, Y Uyar, SD Tekol… - … and Hypothesis in …, 2023 - xiahepublishing.com
Methods The present study serves as evidence for this treatment. The application of
disinfectants in percentage formulations has been officially accepted by the World Health …

[PDF][PDF] Complementary application of the ozonized saline solution in moderate and severe patients with pneumonia Covid-19: efficacy and tolerability

A Schwartz, G Martínez-Sánchez, A Menassa de Lucía… - Preprint, 2020 - ozoderm.co
Currently, there is no effective antiviral therapy recommended for the new coronavirus
disease 2019 pneumonia (COVID-19). The purpose of this study was to evaluate the safety …

In Vitro Analysis of the Anti-viral Potential of nasal spray constituents against SARS-CoV-2

ML Cannon, JB Westover, R Bleher… - bioRxiv, 2020 - biorxiv.org
Viral pandemics have taken a significant toll on humanity and the world now is contending
with the SARS-CoV-2 epidemic. Readily available economical preventive measures should …